SCHEMBL25786355

SCHEMBL25786355

Cc1cnc2[nH]c(-c3ccnn3C)cc2c1Cl

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AURKB Q96GD4 4/20 0.42
▸ INCENP Q9NQS7 4/20 0.42
▸ AXL P30530 1/20 0.42
▸ PRKCI P41743 1/20 0.42
▸ EGFR P00533 1/20 0.42
▸ COMT P21964 1/20 0.41
▸ TBK1 Q9UHD2 1/20 0.38
▸ CCNE1 P24864 1/20 0.37
▸ CDK2 P24941 1/20 0.37
▸ AURKA O14965 3/20 0.36
▸ TPX2 Q9ULW0 3/20 0.36
▸ ALDH1A1 P00352 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ HAVCR2 Q8TDQ0 1/20 0.34
▸ SLC2A1 P11166 1/20 0.34
▸ TLR9 Q9NR96 1/20 0.34
▸ TLR8 Q9NR97 1/20 0.34
▸ TLR7 Q9NYK1 1/20 0.34
▸ IDH1 O75874 2/20 0.33
▸ PDPK1 O15530 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25781281 0.74 CCNE1 (0.47) AURKBINCENPEGFRCOMTTBK1
SCHEMBL25781891 0.73 COMT (0.43) AURKBINCENPEGFRCOMTTBK1
SCHEMBL16977985 0.71 KIT (0.54) AXLPRKCIEGFR
SCHEMBL15962870 0.70 AXL (0.53) AXLPRKCI
SCHEMBL25781276 0.68 RIPK1 (0.50) COMT
SCHEMBL22524317 0.66 EGFR (0.56) AURKBINCENPEGFRCOMTALDH1A1
SCHEMBL25785122 0.66 CYP11B1 (0.38) AURKBINCENPEGFRCOMTHAVCR2
SCHEMBL4373960 0.65 AXL (0.47) AXLPRKCI
SCHEMBL25784855 0.65 CCNE1 (0.63) AURKBINCENPEGFRCOMTTBK1
SCHEMBL1354627 0.65 AURKB (0.57) AURKBINCENPCDK2AURKATPX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023168686-A1 SUBSTITUTED CYCLOPENTANES AS CDK2 INHIBITORS QILU REGOR THERAPEUTICS INC. (CN) 2023-09-14 — — WO disclosed
WO-2023116884-A1 CDK2 INHIBITORS AND USE THEREOF QILU REGOR THERAPEUTICS INC. (CN) 2023-06-29 — — WO disclosed
Send feedback